Mind Map by zoe_whitwell, updated more than 1 year ago
Created by zoe_whitwell about 5 years ago


Biological basis of psychopathology

Resource summary

1 Glia
1.1 Astrocytes
1.1.1 Bond with capillaries to form the BBB
1.1.2 Surrond neurons and hold them in place
1.1.3 Supply nutrients and oxygen
1.1.4 Synaptic transmission (clearance of NT and release gliotransmitters)
1.2 Oligodendrocytes
1.2.1 Produce myelin for axons
1.2.2 Insulation
1.3 Microglia
1.3.1 immune cells
1.3.2 Destroy pathogens and remove dead neurons
1.4 Ependymal cells
1.4.1 Line cerebral ventricles
1.4.2 Cilia: circulate the CSF
2 Neurotransmitters
2.1 Dysregulation of NT systems may be important in the physiology of neuropsychiatric disease
2.1.1 Glutamate/dopamine (schizophrenia) The Dopamine Hypothesis: symptoms due to disturbed and hyperactive dopaminergic signal transduction Glutamate Hypothesis: schziophrenia reflects diminished activation of NMDA receptors in the brain
2.1.2 GABA (anxiety/panic)
2.1.3 Serotonin (depression) Monoamine Hypothesis: dysregulation of the serotonin system depression associated with deficiency of catecholamines (NE) at functionally important adrenergic receptor sites Serotonin Biosynthesis L-tryptophan synthesized Then hydrolysed - becomes 5-HTP Carboxylased by L-amino acid decarboxylase and becomes serotinin (5-HT) Oxidation by monoamine oxidase to the corresponding aldehyde Oxidation by aldehyde hydrogenase to 5-Hydroxyindoleacetic acid (5-HIAA)
3 Neuroanatomy
3.1 Schizophrenia
3.1.1 Ventricular enlargement
3.1.2 Grey matter volume decrease First episode: hippocampaus, thalamus, amygdala, anterior cingulate Chronic: medial and left dorsolateral prefrontal cortex and left suprerior temporal gyrus
3.1.3 White matter abnormalities First episode: inferior longitudinal fasciculus Chronic: right forceps, left forceps minor, splenium of corpus callosum
3.1.4 Microcircuitry changes Cellular disarray in the hippocampus Pyramidal cells reduced in size and packed more densely
3.1.5 Functional neuroanatomical changes (hypofrontality)
3.2 GAD
3.2.1 Amygdala hyperactivation
4 Neuropharmacology
4.1 Agonist: binds to the receptor and initiates a response like that of the endogenous NT
4.1.1 Anxiety Buspirone: 5-HT1A receptor agonists
4.2 Antagonist: (usually a drug) binds the the receptor and interferes with the action of the endogenous NT
4.2.1 Psychosis Chlorpromazine: DA receptor antagonist PCP: non-competitive NMDA receptor antagonist
4.2.2 Depression Iproniazid: MAOI Imipramine: increases brain levels of catecholamines and 5-HT (tricyclic antidepressants) SSRI's
4.2.3 Anxiety Benzodiazepines Bind to GABA receptors SSRI's Pregabalin: Ca2+ receptor antagonist
Show full summary Hide full summary


definitions of abnormality
Daisy U
Monoamine pharmacology -Antidepressant drugs - Dr. Emma Robinson
Anna mph
General Anaesthetics Part 1 - Steve Fitzjohn
Anna mph
Cognition and Dementia - Alzheimer's disease.
Anna mph
Local Anaesthetics
Anna mph
Drug Abuse and Drug Addiction - L1
Anna mph
Design of competitive NMDAR Agonists
Anna mph
General Anaesthetics Part 2 - Steve Fitzjohn
Anna mph
Excitatory amino acids - AMPA and Kainate receptors subtypes
Anna mph
Excitatory amino acids - Excitotoxicity
Anna mph
Opioid Analgesia - Steve Fitzjohn
Anna mph